Literature DB >> 12423773

High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients.

Jo Nijs1, Garth L Nicolson, Pascale De Becker, Danny Coomans, Kenny De Meirleir.   

Abstract

Prevalence of Mycoplasma species infections in chronic fatigue syndrome (CFS) has been extensively reported in the scientific literature. However, all previous reports highlighted the presence of Mycoplasmas in American patients. In this prospective study, the presence of Mycoplasma fermentans, M. penetrans, M. pneumoniae and M. hominis in the blood of 261 European CFS patients and 36 healthy volunteers was examined using forensic polymerase chain reaction. One hundred and seventy-nine (68.6%) patients were infected by at least one species of Mycoplasma, compared to two out of 36 (5.6%) in the control sample (P<0.001). Among Mycoplasma-infected patients, M. hominis was the most frequently observed infection (n=96; 36.8% of the overall sample), followed by M. pneumoniae and M. fermentans infections (equal frequencies; n=67; 25.7%). M. penetrans infections were not found. Multiple mycoplasmal infections were detected in 45 patients (17.2%). Compared to American CFS patients (M. pneumoniae>M. hominis>M. penetrans), a slightly different pattern of mycoplasmal infections was found in European CFS patients (M. hominis>M. pneumoniae, M. fermentansz.Gt;M. penetrans).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423773     DOI: 10.1111/j.1574-695X.2002.tb00626.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  12 in total

1.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

Review 2.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

3.  Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  M Hornig; G Gottschalk; D L Peterson; K K Knox; A F Schultz; M L Eddy; X Che; W I Lipkin
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 4.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 5.  Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

Authors:  Benjamin Heng; Gilles J Guillemin; Bahar Kavyani; Brett A Lidbury; Richard Schloeffel; Paul R Fisher; Daniel Missailidis; Sarah J Annesley; Mona Dehhaghi
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

Review 6.  Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

7.  Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Amy D Proal; Paul J Albert; Trevor G Marshall; Greg P Blaney; Inge A Lindseth
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Epidemiological study air disaster in Amsterdam (ESADA): study design.

Authors:  Pauline Slottje; Anja C Huizink; Jos W R Twisk; Anke B Witteveen; Henk M van der Ploeg; Inge Bramsen; Nynke Smidt; Joost A Bijlsma; Lex M Bouter; Willem van Mechelen; Tjabe Smid
Journal:  BMC Public Health       Date:  2005-05-30       Impact factor: 3.295

Review 9.  Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome.

Authors:  Mira Meeus; Jo Nijs
Journal:  Clin Rheumatol       Date:  2006-11-18       Impact factor: 2.980

10.  Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data.

Authors:  Ruud C W Vermeulen; Hans R Scholte
Journal:  J Transl Med       Date:  2006-08-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.